Funding will expand ongoing clinical trials to treat persistent atrial fibrillation and accelerate growth of global Disease Management Programs Morrisville, NC – November 12, 2014 – (GlobeNewswire) nContact, a leader in the development of Arrhythmia Disease Management Programs, announced that it has entered into a $20 million growth capital financing agreement with Hercules Technology Growth →
MOUNT OLIVE, N.J., Nov 11, 2014 (GLOBE NEWSWIRE via COMTEX) — Flowonix Medical Inc., a medical device company focused on providing advanced, implantable drug delivery solutions, today announced that it has obtained debt and equity financing totaling approximately $40 million. The transaction includes $20 million in equity investment, led by a private equity fund managed →
On November 7, 2014, Armentum Partners presented to members of the National Venture Capital Association (NVCA) on debt and non-dilutive capital raising solutions. Managing Partners Brian Demmert, John Markell, and Hutch Corbett were joined on a panel by NEA’s Ryan Drant to provide insights into current debt market conditions and various non-dilutive financing alternatives. “The →
FARMINGTON, CT and PLEASANTON, CA — (Marketwired) — 09/22/14 — Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced it led a $10 million venture loan for IntegenX Inc. (“IntegenX”), the market leader in Rapid Human →
Growth Capital Allows Alimera to Fulfill Its Milestone Obligation Triggered by FDA Approval of ILUVIEN® ATLANTA, Sept. 30, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it has received a $25 million advance from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules). The payment →
LOS ANGELES, Aug. 5, 2014 (GLOBE NEWSWIRE) — Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, and SWK Funding LLC (“SWK”), a wholly-owned subsidiary of SWK Holdings Corporation, as the agent, entered into a credit agreement (the “Credit Agreement”) pursuant to which the lenders party thereto provide Response Genetics (the “Company”) a term →
REDWOOD CITY, Calif. – July 28, 2014 – PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that it has closed up to $50 million in secured debt financing from an investment fund managed by Pharmakon Advisors and $12 million in an extension on its Series B preferred stock. This financing was →
Strength of SMS CRM business model and global reach validated by large investors July 7, 2014 Sunnyvale, CA – July 7, 2014 – mBlox, the largest global provider of application-to-person (A2P) text messaging, today announced the completion of a new capital raise of $43.5 million to fund the continued growth of its global business. “We see →
BRANFORD, Conn. (June 30, 2014) – CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announced that on Friday, June 27, 2014, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with General Electric Capital Corporation (“GECC”). Pursuant to the Loan Agreement, GECC is providing the →
MENLO PARK, Calif.–(BUSINESS WIRE)–Ceterix™ Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, today announced that the company has closed $18 million in new financing. Previous investors Novo A/S, Versant Ventures and 5AM Ventures participated in the round, which also included debt financing from Silicon Valley Bank and Oxford Finance. Armentum Partners acted →